[
  {
    "ts": null,
    "headline": "5 Insightful Analyst Questions From Quest’s Q4 Earnings Call",
    "summary": "Quest Diagnostics delivered a Q4 performance that exceeded Wall Street’s revenue and earnings expectations, prompting a positive market reaction. Management attributed this outcome to strong organic growth across physician, hospital, and consumer channels, with advanced diagnostics and recent partnerships like Fresenius Medical Care and Corewell Health contributing significant volume gains. CEO Jim Davis cited the company’s expansion in specialized testing—such as Alzheimer’s and autoimmune diag",
    "url": "https://finnhub.io/api/news?id=1ff0867ecea838c486252b0fa21f0eb28deba50de72d195934edc027aee4a63e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771306358,
      "headline": "5 Insightful Analyst Questions From Quest’s Q4 Earnings Call",
      "id": 139121402,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DGX",
      "source": "Yahoo",
      "summary": "Quest Diagnostics delivered a Q4 performance that exceeded Wall Street’s revenue and earnings expectations, prompting a positive market reaction. Management attributed this outcome to strong organic growth across physician, hospital, and consumer channels, with advanced diagnostics and recent partnerships like Fresenius Medical Care and Corewell Health contributing significant volume gains. CEO Jim Davis cited the company’s expansion in specialized testing—such as Alzheimer’s and autoimmune diag",
      "url": "https://finnhub.io/api/news?id=1ff0867ecea838c486252b0fa21f0eb28deba50de72d195934edc027aee4a63e"
    }
  }
]